AIM: To study the frequency of vitamin D deficiency in patients with hepatitis C virus (HCV) infection and to evaluate the role of vitamin D supplementation in improving antiviral therapy. METHODS:Sixty-six children aged from 7-14 years (mean ± SD, 11.17±2.293) diagnosed with HCV infection were matched to 28 healthy controls. Serum levels of 25 (OH) D3, calcium, phosphorus, alkaline phosphatase and plasma level of parathormone were measured. Quantitative PCR for HCV was performed Bone density was determined by dual energy X-ray absorptiometry. All cases received conventional therapy, and only 33 patients received vitamin D supplementation. RESULTS: Children with HCV showed significantly increased levels of HCV RNA (P<0.001), parathormone (P<0.01) and decreased vitamin D levels (P<0.05) (33.3% deficient and 43.3% insufficient) compared with controls. Abnormal bone status (Z score -1.98±0.75) was found in ribs, L-spine, pelvis and total body. Cases treated with vitamin D showed significant higher early (P<0.04) and sustained (P<0.05) virological response. There was a high frequency of vitamin D deficiency among the Egyptian HCV children, with significant decrease in bone density. The vitamin D level should be assessed before the start of antiviral treatment with the correction of any detected deficiency. CONCLUSION: Adding vitamin D to conventional Peg/RBV therapy significantly improved the virological response and helped to prevent the risk of emerging bone fragility.
RCT Entities:
AIM: To study the frequency of vitamin D deficiency in patients with hepatitis C virus (HCV) infection and to evaluate the role of vitamin D supplementation in improving antiviral therapy. METHODS: Sixty-six children aged from 7-14 years (mean ± SD, 11.17±2.293) diagnosed with HCV infection were matched to 28 healthy controls. Serum levels of 25 (OH) D3, calcium, phosphorus, alkaline phosphatase and plasma level of parathormone were measured. Quantitative PCR for HCV was performed Bone density was determined by dual energy X-ray absorptiometry. All cases received conventional therapy, and only 33 patients received vitamin D supplementation. RESULTS:Children with HCV showed significantly increased levels of HCV RNA (P<0.001), parathormone (P<0.01) and decreased vitamin D levels (P<0.05) (33.3% deficient and 43.3% insufficient) compared with controls. Abnormal bone status (Z score -1.98±0.75) was found in ribs, L-spine, pelvis and total body. Cases treated with vitamin D showed significant higher early (P<0.04) and sustained (P<0.05) virological response. There was a high frequency of vitamin D deficiency among the Egyptian HCVchildren, with significant decrease in bone density. The vitamin D level should be assessed before the start of antiviral treatment with the correction of any detected deficiency. CONCLUSION: Adding vitamin D to conventional Peg/RBV therapy significantly improved the virological response and helped to prevent the risk of emerging bone fragility.
Entities:
Keywords:
Children; Hepatitis C; Viral response; Vitamin D
Authors: Alper Yurci; Ali Osman Kalkan; Omer Ozbakir; Ahmet Karaman; Edip Torun; Mustafa Kula; Mevlut Baskol; Sebnem Gursoy; Mehmet Yucesoy; Fahri Bayram Journal: Eur J Gastroenterol Hepatol Date: 2011-11 Impact factor: 2.566
Authors: Matthew T Kitson; Gregory J Dore; Jacob George; Peter Button; Geoffrey W McCaughan; Darrell H G Crawford; William Sievert; Martin D Weltman; Wendy S Cheng; Stuart K Roberts Journal: J Hepatol Date: 2012-11-23 Impact factor: 25.083
Authors: Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello Journal: Ital J Pediatr Date: 2018-05-08 Impact factor: 2.638
Authors: Nghiem Xuan Hoan; Hoang Van Tong; Le Huu Song; Christian G Meyer; Thirumalaisamy P Velavan Journal: World J Gastroenterol Date: 2018-01-28 Impact factor: 5.742
Authors: Noemi Hernández-Alvarez; Juan Manuel Pascasio Acevedo; Enrique Quintero; Inmaculada Fernández Vázquez; María García-Eliz; Juan de la Revilla Negro; Javier Crespo García; Manuel Hernández-Guerra Journal: BMJ Open Gastroenterol Date: 2017-03-04
Authors: Franz J J Rieder; Charlotte Gröschel; Marie-Theres Kastner; Karin Kosulin; Johannes Laengle; Rene Zadnikar; Rodrig Marculescu; Martina Schneider; Thomas Lion; Michael Bergmann; Enikö Kallay; Christoph Steininger Journal: J Steroid Biochem Mol Biol Date: 2016-08-09 Impact factor: 4.292